Effect of Instrument Assisted Soft Tissue Mobilization on Hand Post Surgical Scars in Primary Flexor Tendons Repair in Zone v
Launched by CAIRO UNIVERSITY · May 29, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into a treatment called Instrument Assisted Soft Tissue Mobilization (IASTM) to see how it affects scars on the hand after surgery to repair certain tendons. The researchers want to find out if this method can help improve the appearance and flexibility of scars that form after surgery in a specific area of the hand.
To be eligible for this study, participants should be between 20 and 40 years old and have scars in the targeted area of the hand following tendon surgery. Both men and women can join, but people with certain conditions like significant injuries, fractures, or unhealed wounds are not eligible. If you participate, you can expect to receive treatment focused on your scar and be monitored throughout the study to see how well it works. This trial is not yet recruiting, so stay tuned for updates on when you can apply!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both sex will be included in this research
- • Hand scar in zone v
- • Age varying from 20 to 40
- • Hand scar formed post primary flexor tendons repair
- Exclusion Criteria:
- • Vascular injuries requiring arterial repair
- • Soft tissue loss
- • Fractures
- • Tendon in-juries of other zones
- • Preexisting problems such as arthritis limiting joint motion
- • unhealed wounds or age of scar under 6 weeks
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported